Global Obesity Surgery Devices Market Size By Type (Intragastric Balloons, Gastric Electrical Stimulation), By Application (Minimally Invasive Surgical, Non-invasive Surgical), By Region, And Segment...

The Global Obesity Surgery Devices Market was valued at USD 1.9 billion in 2023 and is projected to surpass USD 3.7 billion by 2031, growing at a CAGR of 8.8% during the forecast period from 2023 to 2031. The rising global obesity burden, increasing preference for minimally invasive bariatric procedures, and technological advancements in surgical devices are fueling market growth. Government initiatives promoting obesity management, alongside growing awareness of obesity-related comorbidities, are further propelling demand for surgical interventions.

Drivers:

1. Rising Prevalence of Obesity:

The growing incidence of obesity, driven by sedentary lifestyles, unhealthy eating habits, and genetic predispositions, is a major driver. According to the World Health Organization, over 650 million adults were obese in 2022, creating a substantial patient base for bariatric surgery.

2. Preference for Minimally Invasive Procedures:

Minimally invasive surgical techniques such as laparoscopic and robotic-assisted surgeries are gaining popularity due to reduced recovery time, lower risk of complications, and better patient outcomes, driving the demand for advanced surgical devices.

3. Technological Innovations in Obesity Surgery Devices:

Ongoing R&D has led to innovative devices like adjustable gastric bands, intragastric balloons, and advanced stapling tools. These developments improve procedure safety and efficacy, boosting surgeon and patient adoption rates.

Restraints:

1. High Cost of Bariatric Surgeries and Devices:

The high procedural and device costs associated with obesity surgeries, coupled with limited insurance reimbursement in certain countries, can restrict market access, especially in developing regions.

2. Postoperative Complications and Surgical Risks:

Despite technological improvements, bariatric procedures still carry risks such as infection, bleeding, or device failure. These concerns can act as a deterrent for both patients and healthcare providers.

Opportunity:

1. Expanding Market Penetration in Emerging Economies:

Asia-Pacific and Latin America are emerging as high-growth regions due to rising obesity rates, improving healthcare infrastructure, and increasing awareness of surgical treatment options.

2. Integration with AI and Robotics:

The adoption of robotic-assisted surgeries and AI-driven preoperative planning tools presents new opportunities for precision, reduced complications, and improved surgical outcomes.

Market by System Type Insights:

Based on system type, the gastric bypass surgery devices segment accounted for the largest market share in 2023. Its dominance is due to the high success rate of gastric bypass in achieving sustained weight loss and resolution of comorbidities like type 2 diabetes. However, the gastric balloon devices segment is expected to register the fastest growth, owing to its non-invasive nature and increasing use in outpatient settings.

Market by End-use Insights:

In terms of end-use, the hospitals segment led the market in 2023, accounting for over 50% of global revenue. Hospitals are equipped with advanced surgical infrastructure and skilled bariatric surgeons, making them the primary choice for obesity-related surgeries. Ambulatory Surgical Centers (ASCs) are gaining traction due to their cost efficiency and faster turnaround times.

Market by Regional Insights:

North America dominated the Global Obesity Surgery Devices Market in 2023, driven by the high obesity prevalence, favorable reimbursement environment, and advanced healthcare infrastructure. Meanwhile, Asia-Pacific is expected to witness the highest CAGR during the forecast period, with countries like India and China experiencing rapid growth in obesity rates and healthcare access.

Competitive Scenario:

Key players in the market include Medtronic plc, Johnson & Johnson (Ethicon), Apollo Endosurgery, ReShape Lifesciences Inc., Spatz FGIA, Cousin Biotech, and Aspire Bariatrics. These companies are focusing on strategic collaborations, regulatory approvals, and product innovations to maintain competitive advantage.

Key Market Developments:

In March 2024, Medtronic launched an AI-integrated laparoscopic stapling system for precision bariatric surgeries.

Apollo Endosurgery received FDA approval in 2023 for its next-generation intragastric balloon system designed for minimally invasive weight loss.

In 2022, Johnson & Johnson announced the expansion of its robotic surgery division with a focus on bariatric applications.

Scope of Work – Global Obesity Surgery Devices Market

FAQs

1) What is the current market size of the Global Obesity Surgery Devices Market?

The market was valued at USD 1.9 billion in 2023.

2) What is the major growth driver of the Global Obesity Surgery Devices Market?

The rising prevalence of obesity and increasing preference for minimally invasive surgical procedures are key growth drivers.

3) Which is the largest region during the forecast period in the Global Obesity Surgery Devices Market?

North America holds the largest market share, while Asia-Pacific is projected to be the fastest-growing region.

4) Which segment accounted for the largest market share in the Global Obesity Surgery Devices Market?

The gastric bypass surgery devices segment led the market in 2023.

5) Who are the key market players in the Global Obesity Surgery Devices Market?

Key players include Medtronic, Johnson & Johnson (Ethicon), Apollo Endosurgery, and ReShape Lifesciences.